1. Agudelo Higuita NI, Brunetti E, McCloskey C. Cystic Echinococcosis. J Clin Microbiol. 2016;54(3):518-23. [
DOI] [
PubMed]
2. Moro P, Schantz P. Echinococcosis: a review. Int J Infect Dis. 2009;13:125–133. [
DOI] [
PubMed]
3. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17(1):107-35. [
DOI] [
PubMed]
4. Gessese AT. Review on epidemiology and public health significance of hydatidosis. Vet Med Int. 2020;3:2020:8859116. [
DOI] [
PubMed]
5. Fasihi Harandi M, Budke CM, Rostami S. The Monetary Burden of Cystic Echinococcosis in Iran. PLoS Negl Trop Dis. 2012;6(11):e1915. [
DOI] [
PubMed]
6. Rokni MB. Echinococcosis/hydatidosis in Iran. Iran JParasitol. 2009;4(2):1-16.
7. Pagnozzi D, Addis MF, Biosa G, Roggio AM, Tedde V,Mariconti M, et al. Diagnostic accuracy of antigen 5-basedELISAs for human cystic echinococcosis. PLoS Negl Trop Dis. 2016;10(3):e0004585. [
DOI] [
PubMed]
8. World Health Organization.Echinococcosis. WHO: 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/echinococcosis.
9. Bahrami Moghadam M, Hajilooi M, Fallah M, Maghsood AH,Matini M. Seroprevalence of hydatidosis in outpatientsattending health centers in Hamadan city, 2017. Avicenna JClin Med. 2018;25(2):99-104. [
DOI]
10. Barati R , Sharifi-Sarasiabi K, Hamedi Y , Matini M , Shamseddin J. Seroprevalence of hydatidosis in Kaboodarahang, Hamadan Province, Iran, in 2016 - 2017, Hormozgan. Med J. 2018;22(4):e86498. [
DOI]
11. Akhlaghi L, Massoud J, Housaini A. Observation on hydatidcyst infection in Kordestan province (West of Iran) usingepidemiological and seroepidemiological criteria. Iran J Public Health. 2005; 34(4):73-5.
12. Baharsefat M, Massoud J, Mobedi I, Farahnak A, Rokni MB. Seroepidemiology of human hydatidosis in Golestan Province, Iran. Iran J Parasitol. 2007; 2(2):20–4.
13. Hezarjaribi HZ, Fakhar M, Rahimi Esboei B, Soosaraei M, Ghorbani A, Nabyan N, et al. Serological evidence of humancystic echinococcosis and associated risk factors amonggeneral population in Mazandaran Province, northern Iran. Ann Med Surg. 2017;18:1-5. [
DOI] [
PubMed]
14. Shafiei R, Teshnizi SH, Kalantar K, Gholami M, Mirzaee G, Mirzaee F. The seroprevalence of human cystic echinococcosis in Iran: a systematic review and meta-analysis study. J Parasitol Res. 2016;2016:1425147. [
DOI] [
PubMed]
15. Asghari M, Mohebali M, Kia EB, Farahnak A, Aryaeipour M, Asadian S, Rokni MB. Seroepidemiology of human hydatidosis using AgB-ELISA test in Arak, Central Iran. Iran J Public Health. 2013;42(4):391-396. [
PubMed]
16. Ilbeigi P, Mohebali M, KIA EB, Saberinasab M, AryaeipourM, Bizhani N, et al. Seroepidemiology of human Hydatidosis using AgB-ELISA test in Isfahan city and Suburb areas,Isfahan province, central Iran. Iran J Public Health. 2015;44(9):1219-24. [
PubMed]
17. Rakhshanpour A, Harandi MF, Moazezi SS, Rahimi MT,Mohebali M, Mowlavi GR, et al. Seroprevalence of humanhydatidosis using ELISA method in Qom Province, CentralIran. Iran J Parasitol. 2012;7(3):10-5. [
PubMed]